by Audrey Labrie | Dec 10, 2018 | Other
Data from evaluations and trials conducted at hospitals across North America and Europe consistently show that prophylactic transfusions of activated platelets lead to more transfusions per patient, shorter intervals between transfusions, and more patients requiring... by Audrey Labrie | Nov 28, 2018 | Literature Review
While we at ThromboLUX are mostly focused on improving the outcomes of platelet transfusions, we also strive to improve transfusion medicine as a whole. This is why we were excited to collaborate with Dr. Jason Acker and Ruqayyah Almizraq on a publication which... by Audrey Labrie | Nov 14, 2018 | Literature Review
While the term “evidence-based medicine” wasn’t coined until the 1990s, we have long strived to improve medical practice by generating evidence through trials. One could argue that recorded medical trials started as far back as the Book of Daniel, with the frequency... by Dan Millar | Oct 31, 2018 | Other
The AABB annual meeting is always an exciting and busy time of year. We know that many people interested in transfusion medicine weren’t able to attend, and even those who attended couldn’t make it to every talk, it is impossible to fit it all in. We would like to... by Dan Millar | Oct 5, 2018 | Abstract Preview
Similar to our previous blog posts covering the AABB abstracts from Vancouver General Hospital, The University of Colorado Hospital, and Vienna General Hospital this post covers an abstract generated by a hospital that recently evaluated ThromboLUX. This time we are... by Dan Millar | Sep 28, 2018 | Abstract Preview
Similar to our previous blog posts covering the AABB abstracts from Vancouver General Hospital and The University of Colorado Hospital, this post presents an abstract generated by a hospital that recently completed a study using ThromboLUX. This time we are looking at... by Dan Millar | Sep 20, 2018 | Abstract Preview
Similar to the previous blog post covering the AABB abstracts from the Vancouver General Hospital study, this post will cover an abstract generated by a hospital that has recently evaluated ThromboLUX. This time we are looking at the work done by Dr. Inga Gurrevich,... by Dan Millar | Sep 13, 2018 | Abstract Preview
Over the next four weeks, this blog will be previewing upcoming AABB 2018 abstracts that feature ThromboLUX. This post covers two abstracts that came out of one study. The data set generated during a randomized controlled trial conducted at Vancouver General Hospital... by Dr. Elisabeth Maurer-Spurej | Aug 28, 2018 | Literature Review
This page is Part 2 of a two-part blog post on the impact of ABO matching for platelet transfusion. Part 1 provides provide an overview of the ABO system as it applies to platelets, definitions of ABO platelet matching terminology, and common endpoints for studies... by Dr. Elisabeth Maurer-Spurej | Aug 27, 2018 | Literature Review
There has been an ongoing debate over the importance of ABO matching for platelet transfusions for well over 50 years. A survey from 2007 showed that 17% of North American institutions did not have a formal ABO policy and 50% of the institutions with a policy gave ABO... 